Ruby Gadelrab is the CEO and Co-Founder of MDisrupt. She is a seasoned digital health executive with a track record in successfully commercializing healthcare and healthtech products. She served on the executive team at 23andMe as VP of commercial marketing and has worked for many leading companies in the biotech and genetic spaces. Before founding MDisrupt, Ruby consulted for, advised, and mentored more than 25 digital health companies.

Melissa Reilly is a transformation-focused behavioral healthcare executive with more than a dozen years of leadership experience building and scaling healthcare technology companies. Melissa recently started a healthcare consulting business and has been focusing on expanding her advisory and board work after leaving Evernorth Behavioral Health, where she was the Chief Growth Officer, leading strategy and business development. Currently, she holds several advisory and for profit and non-profit board roles all focused on vulnerable populations. Melissa is passionate about reducing behavioral health stigma, generating awareness regarding the importance of prioritizing behavioral health, and developing scalable solutions for (mental) health and substance use that maximize quality and access to care.

Melissa previously served as Vice-President of Strategy and Partnerships at Digital Diagnostics, an AI-based, venture-backed startup, from 2020 to 2021 focused on introducing and commercializing novel technology. Melissa cultivated growth, operational and change agent experience at Optum, working closely with many Optum Venture portfolio companies as its Vice-President of Business Development and Commercialization from 2018 to 2020. There, she helped coach and mentor portfolio companies, championed the development of integrated offerings within the organization, and supported innovation for enterprise partners across multiple lines of business.

Melissa spent most of her career in the behavioral health and growth roles at Optum. As the Vice-President of Strategic Initiatives for Behavioral Health, she was responsible for lead product development, driving growth through innovative partnerships and introducing a new technology delivery process. From 2012 to 2016, she also served as Senior Director for Strategic Growth Initiatives at UnitedHealth Group establishing and then leading several partnerships with Fortune 50 clients and national sponsorship partners. In addition, Melissa leveraged her analytic mindset in several enterprise consulting and compliance positions prior to her directorship.

Melissa received a B.B.A. in Finance from James Madison University, and holds both an M.B.A. in Healthcare Management and a J.D. with Health Law concentration from Quinnipiac University. Melissa resides in Connecticut, with her husband and three children.

Zeev Neuwirth, MD most recently served as the Chief Clinical Executive for Care Transformation & Strategic Services at Atrium Health (now a part of Advocate Health), one of the leading non-profit hospital systems in the country. Dr. Neuwirth has nearly 15 years of experience in clinical operations, care redesign, quality improvement, innovation, and population health. He has served as an industry adviser to numerous digital health companies.

In 2017 Dr. Neuwirth launched an award-winning podcast entitled Creating a New Healthcare which has over 150 posted episodes of in-depth interviews with healthcare entrepreneurs and leaders.

In 2019, Dr. Neuwirth published Reframing Healthcare – A Roadmap for Creating Disruptive Change. This book achieved Amazon #1 New Release status in the domain of healthcare administration and policy. Based on in-depth interviews with hundreds of healthcare leaders and entrepreneurs, it outlines the market trends reshaping healthcare; and a comprehensive and scalable approach to transforming healthcare delivery.

Dr. Neuwirth has published a second book, Beyond The Walls – the megatrends, movements & market disruptions transforming American healthcare. It illustrates a market-based, three-part strategy for how the transformation of American healthcare is occurring.

Dr. Neuwirth is an alum of Tufts University and the University of Pennsylvania School of Medicine. He received a Masters in Healthcare Management from the Harvard School of Public Health, where he taught and lectured on healthcare strategy and innovation. He currently is a lecturer at the Yale School of Public health.

As Providence’s Group VP and Chief of Virtual Care and Digital Health, Dr. Cunningham leads a team of 100+ caregivers and 250 providers that offer a care delivery portfolio including 9 enterprise virtual care service lines, hospital-at-home, remote patient monitoring, a virtual nursing team, virtual behavioral health platform, and the MedPearl a digital assistant. Her team has launched virtual care services to 100 + sites across 8 states.

Dr. Cunningham joined Providence St. Joseph Health in 2017 as the Chief Medical Officer of Providence Medical Group Southwest. She is board certified in Obstetrics and Gynecology and has practiced for over 12 years in the South Puget Sound community. Prior to joining Providence, Dr. Cunningham served as Service Line Medical Director and Division Chief of Women’s, Children’s, Urgent Care and Virtual Care Services at CHI- Franciscan Health (currently, Virginia Mason Franciscan Health) in Tacoma, WA.

During her time at both CHI and Providence, Dr. Cunningham has developed a strong passion for applied technologies and care transformation in healthcare, with a goal of improving the cross-continuum care experience.

Dr. Cunningham has a strong background in clinical informatics, clinical operations, and leading transformational change. Dr. Cunningham received her medical degree at Saint Louis University School of Medicine and postgraduate residency training at Kaiser Los Angeles Medical Center. She received her Master’s in Business Administration from University of Massachusetts- Amherst.